Brief: Tianjin Development Says HY Net Profit For Tianjin Lisheng Pharmaceutical Of RMB101.3 Million
23/08/2024 02:27
Aug 23 (Reuters) - Tianjin Development:
* HY NET PROFIT FOR TIANJIN LISHENG PHARMACEUTICAL OF
RMB101.3
MILLION
* HY TOTAL OPERATING INCOME FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB744.6 MILLION VERSUS RMB657.5 MILLION
Further company coverage: 002393.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln